knowledge -WSS

knowledge

author：hotspot 2025-10-01 04:44:56 - browse：94742

The Food and Drug Administration is poised to tell drug and medical device makers how to better include people of color in the clinical trials that test whether products work and are safe, an agency official said Wednesday. Those guidelines are five months late.

To ensure that drugs work for everyone, they must be tested on a representative sample of people. But researchers have found that many clinical trials exclude the people of color who are often most affected by the diseases that drugs treat.

To help fix that problem, Congress passed a law requiring companies to give the FDA their plans for diversifying clinical trials. As part of that process, the agency was expected to issue guidance by the end of last year.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Noem? Reynolds? A very early look at the Republican 'veepstakes'

WSS

More doctors should go into startup world

Some in Scotland's Orkney Islands want to return to Norway after 550 years

Diversify hospital leadership teams to protect BIPOC patient health

NASA releases new images of 'fingerprint

A timeline of the missing Titanic tourist submersible

More doctors should go into startup world

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

US ambassador visits Wall Street Journal reporter detained in Russia on charges of espionage

How to save PrEP access — and even expand it

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

Apple is now the first public company to be valued at $3 trillion

Noem? Reynolds? A very early look at the Republican 'veepstakes'

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Greece's new parliament sworn in following conservative party's election victory

How one medical school became remarkably diverse

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

leisure time

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

UCSF medical school apologizes for unethical prisoner experiments

Will General Catalyst be the first of many hospital takeovers?

Study: New antibiotic targets gonorrhea as well as last existing drug

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

focus

leisure time

hotspot

leisure time